Company
MetaCell s.r.o., a cancer diagnostics company, is engaged in the development and commercialization of proprietary circulating tumor cells, disseminated tumor cells and circulating endometrial cells.
The offered tests provide information to oncologists and gynecologists enabling them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumor or endometrial cells detected in circulation or bodily fluids.
MetaCell s.r.o., is a cancer research company providing contract drug discovery and evaluation service to pharmaceutical and biotechnology companies. The company sells its products and services through own sales force and partners focusing on selling directly to diagnostic and research community worldwide.
ONCOLOGY:
CTCs & DTCs & CTM- MetaCell® Nonetheless, detection and isolation of CTCs is technically quite challenging. First, there is a relative small number of CTCs in peripheral blood, approx. 1 CTC to 106–109 normal blood cells. A second challenge comes from their biological heterogeneity. The most popular methods for CTCs isolation are immunomagnetic enrichment, size-based filtration and density gradient methods.
GYNECOLOGY:
Endometriosis test- Endometriosis is a common disorder amongst women of reproductive age. Endometriosis, the presence of endometrial-like tissue outside the uterus, is a disease associated with pelvic pain and infertility. Endometriosis afflicts about 10% of women worldwide. In women with pain, infertility or both, the frequency of endometriosis increases to 35-60%. It is one of the most frequent benign…
CONTRACTING
Service and research- MetaCell s.r.o., a biotechnology company on the field of cell separation and cultivation procedures expansion, is developing a new, diagnostic assay for personalized medicine. The test could be used in early detection, diagnosis and monitoring of cancer and endometriosis treatment.
- MetaCell s.r.o., provides customized …